While the prevalence of COVID-19 in patients with COPD is relatively low, those who are infected with the virus experience more severe symptoms than those without COPD.
Jenny Quach, PharmD Student Class of 2021
Advertisement
Articles by Jenny Quach, PharmD Student Class of 2021
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Capvaxive Expanded Indication to Include Children, Adolescents at Increased Risk for Pneumococcal Disease
2
FDA Clears First Single-Inhaler Triple Therapy for Asthma
3
Metformin Cuts Long COVID Risk by 50%, New Trial Confirms
4
FDA Clears the Way for First Generic Single-Dose Flu Treatment Ahead of 2026 Season
5